Three strategies for lowering your tax liability under the new R&D tax rules
For tax years ending December 31, 2021 and prior, companies could deduct their entire research and development (R&D) costs on …
Learn More
Services: Corporate Tax, Section 382
Industries: Life Science, Technology
Gladys is a Tax Director at BPM. She has 20 years of experience in public accounting and specializes in corporate tax services, particularly for pre-revenue venture-backed start-up companies and public companies in the high-tech, biotech, and life science sectors. Her extensive knowledge extends to businesses with multi-state and international operations.
Gladys has a broad range of experience with corporate tax compliance, tax provisions (FAS 109 / ASC 740) and conducting Section 382 studies to determine limitations on tax attributes.
Gladys (Ho Yee) Tam holds an active CPA license in California.
Gladys enjoys building Legos and collecting miniatures!
Certified Public Accountant
BS/Finance – California State University, East Bay
Cantonese
For tax years ending December 31, 2021 and prior, companies could deduct their entire research and development (R&D) costs on …
Learn More
As a result of the COVID-19 pandemic, many businesses are facing financial challenges including declining revenue and rising operating costs. …
Learn More
This article originally appeared on October 1, 2019 in the San Francisco Business Times and Silicon Valley Business Journal. It often …
Learn More